|
|
Volumn 14, Issue 8, 2003, Pages 1165-1166
|
|
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of osteosarcoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
FOLINIC ACID;
IFOSFAMIDE;
METHOTREXATE;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD ANALYSIS;
BLOOD CHEMISTRY;
BONE BIOPSY;
BONE METASTASIS;
BONE RADIOGRAPHY;
BONE SCINTISCANNING;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
COMPUTER ASSISTED TOMOGRAPHY;
FOLLOW UP;
HEALTH CARE ORGANIZATION;
HISTOPATHOLOGY;
HUMAN;
LUNG METASTASIS;
ORTHOPEDIC SURGERY;
OSTEOSARCOMA;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
SALVAGE THERAPY;
THORACOTOMY;
TREATMENT PLANNING;
TUMOR LOCALIZATION;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CHILD;
FEMALE;
FOLLOW-UP STUDIES;
HEALTH PLANNING GUIDELINES;
HUMANS;
MALE;
NEOPLASM STAGING;
ORTHOPEDIC PROCEDURES;
OSTEOSARCOMA;
RISK ASSESSMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0042385030
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdg336 Document Type: Article |
|
Times cited : (8)
|
|
References (4)
|
